LFTD PARTNERS INC.

LIFD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2011 FY2010
Revenue $460.5K $4.9M
Cost of Revenue $192.5K $2.5M
Gross Profit $268.0K $2.3M
Gross Margin 58.2% 48.3%
Operating Expenses
Research & Development
SG&A Expense $208.2K $2.5M
Operating Income $-208.2K $-124.1K
Operating Margin -45.2% -2.6%
Interest Expense $19.1K $63.1K
Pretax Income $-4.3M $-187.2K
Income Tax Expense $800 $13.5K
Net Income $-4.3M $-200.7K
Net Margin -933.9% -4.1%
EPS (Basic) $-0.47 $-0.02
EPS (Diluted) $-0.47 $-0.02
Shares Outstanding (Basic)
Shares Outstanding (Diluted) 9.2M 8.7M
Dividends Per Share
← Newer Page 2 of 2 Older →